Lobbying Filing Details
Total Spending
$450,000
Activities
3
Lobbyists
3
Gov't Entities
6
Filing Information
- Filing UUID:
17780ebb-228e-4a40-b730-e60dcc381d66- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 20, 2026 at 11:39 PM
- Income:
- $0
- Expenses:
- $450,000
- Expense Method:
- A
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Deirdre Parsons
Registrant
ALNYLAM PHARMACEUTICALS, INC.
Cambridge, MassachusettsClient
ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical manufacturer
Massachusetts, United States of AmericaLobbying Activities (3)
Activity 1
Medicare/MedicaidIssues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing
Lobbyists (3)
- MS. DEIRDRE BRADFORD PARSONS
- CURTIS RHYNE
- MARGARET HERMAN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
PharmacyImplementation of The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (PL 116-94); issues related to drug pricing; FY2026 Labor HHS appropriations, issues related to genetically targeted technologies; HR1672, Maintaining Investments in New Innovation Act.
Lobbyists (3)
- MS. DEIRDRE BRADFORD PARSONS
- CURTIS RHYNE
- MARGARET HERMAN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Trade (domestic/foreign)Issues relating to supply chain tariffs
Lobbyists (3)
- MS. DEIRDRE BRADFORD PARSONS
- CURTIS RHYNE
- MARGARET HERMAN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES